IXP Launches Maiden Rs 2 Bn Fund to Fuel Biotech Innovation
ECONOMY & POLICY

IXP Launches Maiden Rs 2 Bn Fund to Fuel Biotech Innovation

IXP, a Lifesciences VC backed by JV Ventures, has announced the launch of it’s first fund to invest in early-stage companies. The fund aims to build a portfolio of B2B companies ranging from Pre-seed to Series A stages.

The IXP Lifesciences Catalyst Fund is targeting a corpus of Rs 2 billion with a greenshoe option of Rs 1 billion. The fund plans to create a portfolio of 20-25 companies addressing gaps in the market for both services and products. Within the Lifesciences sector, the fund will invest across innovation in areas such as pharma, biotechnology, medical technology, speciality chemicals, agrotechnology and nutraceuticals.

Ketki Tulpule, Ph.D., CIO at IXP said, “IXP was born out of a need we saw in the Indian start-up ecosystem. In fact, we conducted a pan-India survey to understand the pain points of biotech’s for an outside-in perspective. The sector is nuanced, and requires investors with scientific expertise, industry knowledge, and operational experience to help biotech’s succeed. We are glad to have onboarded industry veterans as council members and advisors who add to the scientific heft of the fund”.

Vishal Goel, Partner at IXP and Co-founder of JV Ventures commented, “The Indian Lifesciences industry is dynamic with large untapped potential. Through IXP Venture Studio, we will co-create companies along with scientists for ideas addressing unmet needs in the market. Unlike traditional VCs, IXP has a hands-on approach through active participation from concept to scale. The Ventureprenuer Program has been designed to transform scientists into founders”.

Jasmeet Chhabra, Partner at IXP and Co-founder of JV Ventures added, “The success of biotech’s hinges on many factors, not just capital. These early-stage companies require access to larger ecosystems for laboratories, networks and R&D services which we provide through PoweRx, the Lifesciences vertical of JV Ventures. This differentiates IXP from other funds as it leverages synergies within the group to create a winning proposition for portfolio companies.”

Image Source:https://www.msn.com/

IXP, a Lifesciences VC backed by JV Ventures, has announced the launch of it’s first fund to invest in early-stage companies. The fund aims to build a portfolio of B2B companies ranging from Pre-seed to Series A stages. The IXP Lifesciences Catalyst Fund is targeting a corpus of Rs 2 billion with a greenshoe option of Rs 1 billion. The fund plans to create a portfolio of 20-25 companies addressing gaps in the market for both services and products. Within the Lifesciences sector, the fund will invest across innovation in areas such as pharma, biotechnology, medical technology, speciality chemicals, agrotechnology and nutraceuticals. Ketki Tulpule, Ph.D., CIO at IXP said, “IXP was born out of a need we saw in the Indian start-up ecosystem. In fact, we conducted a pan-India survey to understand the pain points of biotech’s for an outside-in perspective. The sector is nuanced, and requires investors with scientific expertise, industry knowledge, and operational experience to help biotech’s succeed. We are glad to have onboarded industry veterans as council members and advisors who add to the scientific heft of the fund”. Vishal Goel, Partner at IXP and Co-founder of JV Ventures commented, “The Indian Lifesciences industry is dynamic with large untapped potential. Through IXP Venture Studio, we will co-create companies along with scientists for ideas addressing unmet needs in the market. Unlike traditional VCs, IXP has a hands-on approach through active participation from concept to scale. The Ventureprenuer Program has been designed to transform scientists into founders”. Jasmeet Chhabra, Partner at IXP and Co-founder of JV Ventures added, “The success of biotech’s hinges on many factors, not just capital. These early-stage companies require access to larger ecosystems for laboratories, networks and R&D services which we provide through PoweRx, the Lifesciences vertical of JV Ventures. This differentiates IXP from other funds as it leverages synergies within the group to create a winning proposition for portfolio companies.” Image Source:https://www.msn.com/

Next Story
Infrastructure Transport

Lack of Bidders Stalls VOC Port’s Rs 70.56 Bn Harbour Project Again

The VOC Port Authority’s Rs 70.56 billion outer harbour project has once again faced a setback, with the latest tender process cancelled due to the absence of qualified bidders. This marks the second failed attempt to secure participation for the mega infrastructure initiative.The tender has reportedly been withdrawn from the active list of bids, and the authority is now expected to re-evaluate and possibly restructure the project to enhance its appeal to potential developers.The port authority had initially floated the Request for Proposal (RFP) in December 2024, following the cancellation ..

Next Story
Infrastructure Transport

Sea Lord Containers Opens Cryogenic LPG Terminal in Mangalore

Sea Lord Containers (SCL), a wholly-owned subsidiary of Aegis Logistics, has commissioned a new cryogenic Liquified Petroleum Gas (LPG) terminal in Mangalore. The facility, which became operational on 12 June 2025, offers a static storage capacity of 82,000 metric tons (MT), significantly strengthening the region’s LPG logistics infrastructure.The terminal was developed by SCL on behalf of Aegis Vopak Terminals, an associate company of Aegis Logistics. The asset is expected to be transferred to Aegis Vopak Terminals Limited at a later date, with formal updates to be shared separately with st..

Next Story
Infrastructure Urban

Cochin Port and Oil India Partner for Offshore Exploration Support

The Cochin Port Authority (CoPA) has signed a Memorandum of Understanding (MoU) with Oil India (OIL) to establish a shore base facility supporting offshore oil exploration in the Kerala-Konkan Basin. The agreement was formalised at a ceremony held at CoPA, Willingdon Island, on 12 June 2025, in the presence of senior officials from both organisations.Under the partnership, Cochin Port will provide critical logistics infrastructure for OIL’s offshore drilling operations, expected to begin later in 2025. The planned shore base will include a dedicated warehouse, dry bulk handling plant, and an..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?